ACE Pharmaceuticals has sold a majority stake to private investors and Quadrum Capital
The shareholders of ACE Pharmaceuticals have sold a majority stake in the company to private investors and Quadrum Capital, a Dutch private equity firm.
ACE Pharmaceuticals is a specialized company operating in the niche of medical need products which provide mainly small patient groups or specific indications. Through new, innovative products or by the revitalization of orphaned drugs, the company is able to ensure that these medical need products are or remain available. The company develops and distributes locally and abroad both licensed and non-licensed products. ACE Pharmaceuticals was founded more than 25 years ago as a producer of veterinary medicines. In the early 2000s, the company shifted its focus to human medical need products. Since then, it has experienced strong sales growth and has built an exciting product range and promising product pipeline.
Oaklins's team in the Netherlands acted as M&A advisor to the shareholders of ACE Pharmaceuticals in this transaction.
Neem contact op met het dealteam
Sander van 't Spijker
Oaklins Netherlands
Gerelateerde deals
Dania Software has been acquired by Omnidocs
The owners of Dania Software A/S have sold the company to Omnidocs.
Lees verderTop Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider
Holland Capital, a Netherlands-based private equity firm, has acquired a stake in Top Systems, a leading provider of complete battery-based power solutions, with a unique value-added services proposition.
Lees verderSoler & Palau Ventilation has acquired subsidiaries of United Enertech Holdings
Soler & Palau Ventilation, Inc. (S&P) has acquired subsidiaries of United Enertech Holdings, LLC. (UEH). The subsidiaries included Air Conditioning Products, LLC; Air Performance, LLC; Metal Form Manufacturing, LLC; and United Enertech Corp.
Lees verder